CG
CRVS icon

Cutler Group’s Corvus Pharmaceuticals CRVS Stock Holding History

Cutler Group’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-400
Closed -$6K – 5419
2021
Q4 		$6K Sell
400
-41,400
-99% -$161K ﹤0.01% 4046
2021
Q3 		$95K Buy
+41,800
New +$124K ﹤0.01% 1955
2020
Q4 		– Sell
-5,200
Closed -$3K – 4900
2020
Q3 		$3K Buy
+5,200
New +$20.8K ﹤0.01% 3793

Other funds holding CRVS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return